Pricing Log in Create free account

ALX Oncology Holdings Inc. (ALXO) vs Molecular Partners AG Sponsored ADR (MOLN)

ALX Oncology Holdings Inc. and Molecular Partners AG Sponsored ADR are both Biotechnology companies. ALX Oncology Holdings Inc. and Molecular Partners AG Sponsored ADR are of similar size ($143.5M and $138.3M). Across the 12 metrics below, Molecular Partners AG Sponsored ADR leads on 7 and ALX Oncology Holdings Inc. on 5.

Valuation

Metric ALXO MOLN Biotechnology median
P/E n/m n/m 8.42
P/S 55.64 25.33 10.01
P/B 1.00 1.93 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 5.06 10.10 9.41
Earnings yield (113.00%) (46.34%) (31.85%)
Free cash flow yield (52.28%) (40.13%) (24.58%)

Profitability

Metric ALXO MOLN Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (80.65%) (63.89%) (56.36%)
Return on assets (63.16%) (52.73%) (48.04%)
Return on invested capital (673.30%) 0.00% 0.00%

Growth

Metric ALXO MOLN Biotechnology median
Revenue growth (TTM) — (27.99%) 6.02%
EPS growth (last fiscal year) 26.36% (9.94%) 30.26%
Revenue growth, 5-year CAGR — (23.12%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALXO MOLN Biotechnology median
Debt to equity 0.07 0.00 0.00
Current ratio 9.71 7.27 4.72
Net debt to EBITDA 0.34 1.66 0.96

Dividend

Metric ALXO MOLN Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ALXO MOLN Biotechnology median
Market cap 138.28m 143.47m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack